RESUMEN

BACKGROUND: It is well known the inverse relationship between health-related quality of life (HRQoL) and the use of consultations. However, most studies deal sex as a confounding variable rather than to explicitly investigate sex differences. The study aims to know the influence of HRQoL of the elderly on the use of Primary Care consultations in a sex analysis. METHODS: Throughout 2013, 191 women and 155 men aged 65 years or older were enrolled in the study and assessed with interviews and analysis of medical records. We used the EuroQol-5D to assess the HRQoL and several demographic, clinical and social support variables were also analyzed. Two multiple linear regression models were developed. RESULTS: HRQoL showed a negative correlation with the use of consultations (Spearman's rho=-0,22; p=0,0001) and a crude OR value of 1,85 (95% CI:1,2-2,9). The association remained significant after adjusting for demographic [OR=1,99 (95% CI: 1,2-3,2)], clinical [OR=1,79 (95% CI: 1,1-2,9)] or social support covariates [OR=1,83 (95% CI: 1,1-2,9)]. In regression analysis, the values of standardized coefficient (ß) related to HRQoL were 0,22 (95% CI:-36,7- -6,9) in females and 0,03 (95% CI:-15,6-23,1) in males. CONCLUSIONS: In women ≥ 65 years, HRQoL shows the greatest explanatory power of use of consultations, after adjusting for demographic, clinical and social support covariates. By contrast, its influence on men is negligible.

Asunto(s)

RESUMEN

Fundamentos: Es conocida la asociación inversa que existe entre la calidad de vida relacionada con la salud (CVRS) y el consumo de consultas. Sin embargo, el sexo es considerado habitualmente como variable de confusión, y son escasos los estudios que han analizado explícitamente las diferencias de sexo en esta cuestión. El objetivo fue conocer la influencia de la CVRS sobre el uso de consultas de Atención Primaria en las personas >65 años, en un análisis diferenciado por sexo. Métodos: La selección de participantes se realizó a lo largo de 2013, 191 mujeres y 155 varones de ≥65 años fueron estudiados mediante entrevista y análisis de historias clínicas. Se utilizó el Cuestionario EuroQol-5D y fueron analizadas variables demográficas, clínicas y de apoyo social. Se elaboraron 2 modelos de regresión múltiple, uno dirigido a las mujeres y otro a los varones. Resultados: La CVRS se correlacionó de forma negativa con el consumo de consultas (Rho-Spearman=-0,22; p=0,0001), con una OR cruda de 1,85 (IC95%: 1,2-2,9). La asociación se mantuvo significativa al ajustar tanto por variables demográficas [OR=1,99 (IC95%: 1,2–3,2)], como por variables clínicas [OR=1,79 (IC95%: 1,1-2,9)] o de apoyo social [OR=1,83 (IC95%: 1,1–2,9)]. En el análisis de regresión, los valores del coeficiente estandarizado (β) asociado a la CVRS fueron 0,22 (IC95%: -36,7– -6,9) en las mujeres, y 0,03 (-15,6–23,1) en los varones. Conclusiones: En las mujeres de ≥65 años la CVRS es la variable con mayor capacidad explicativa de consumo de consultas, tras ajustar por variables demográficas, clínicas y de apoyo social. Por el contrario, en los varones su influencia es prácticamente nula (AU)

Background: It is well known the inverse relationship between health-related quality of life (HRQoL) and the use of consultations. However, most studies deal sex as a confounding variable rather than to explicitly investigate sex differences. The study aims to know the influence of HRQoL of the elderly on the use of Primary Care consultations in a sex analysis. Methods: Throughout 2013, 191 women and 155 men aged 65 years or older were enrolled in the study and assessed with interviews and analysis of medical records. We used the EuroQol-5D to assess the HRQoL and several demographic, clinical and social support variables were also analyzed. Two multiple linear regression models were developed. Results: HRQoL showed a negative correlation with the use of con-sultations (Spearman´s rho=-0,22; p=0,0001) and a crude OR value of 1,85 (95% CI:1,2–2,9). The association remained significant after adjusting for demographic [OR=1,99 (95% CI: 1,2–3,2)], clinical [OR=1,79 (95% CI: 1,1–2,9)] or social support covariates [OR=1,83 (95% CI: 1,1–2,9)]. In regression analysis, the values of standardized coefficient (β) related to HRQoL were 0,22 (95% CI:-36,7– -6,9) in females and 0,03 (95% CI:-15,6–23,1) in males. Conclusions: In women ≥65 years, HRQoL shows the greatest explanatory power of use of consultations, after adjusting for demographic, clinical and social support covariates. By contrast, its influence on men is negligible (AU)

Asunto(s)

RESUMEN

Objetivo Analizar el cribado del cáncer de cuello uterino en Cantabria, evaluando la cobertura y los costes del cribado, y calculando los costes directos conocidos de la enfermedad y los costes indirectos debidos a su mortalidad. Métodos En 189.111 mujeres entre 21 y 65 años de edad (población susceptible de cribado del cáncer de cuello uterino) del padrón del año 2011 de Cantabria se realizó un estudio descriptivo transversal cuantitativo y cualitativo de las citologías realizadas, y se analizaron los costes directos e indirectos debidos al tumor. Resultados Durante los años 2006 a 2011, el 51% de las mujeres del grupo de estudio se realizó una citología, y el 26% dos. En 2011 se hicieron 31.554 citologías en Cantabria y sus costes directos fueron de 2.904.760 Euros. Los costes directos asistenciales debidos al tumor fueron de 567.567 Euros, promedio anual para el periodo 2008-2010. Los costes indirectos anuales (promedio 2001-2008) del cáncer de cuello uterino ascienden a 386.122,02 Euros, en el escenario de referencia considerado. Conclusión Sólo un 26% de las mujeres de Cantabria se realizan citologías con la periodicidad aconsejada en el protocolo oportunista vigente. Los datos de costes presentados en este trabajo pueden ser útiles para futuras evaluaciones económicas(AU)

Objective To analyze cervical cancer screening performed in Cantabria by evaluating the coverage and costs of screening and by calculating the available direct costs of the disease and the indirect costs of cervical cancer mortality. Methods Screening for cervical cancer is performed in women aged between 21 and 65. According to the census for 2011 in Cantabria, there were 189.111 women in this age group. We performed a cross sectional, quantitative and qualitative study of the Pap smears performed and analyzed the direct and indirect costs of cervical cancer. Results Between 2006 and 2011, 51% of women studied had one Pap smear, and 26% had two. In 2011, 31.554 Pap smears were performed in opportunistic screening in Cantabria, and the direct cost was 2,904.760 Euros. The annual direct cost of cervical cancer (average 2008-2010) was 567.567 Euros. The annual indirect costs (average 2001-2008) of cervical cancer was 386.122.02 Euros, in the reference scenario considered. Conclusions Only 26% of women in Cantabria attended screening within the intervals recommended in the current opportunistic protocol. The cost data provided in this study may be useful for future economic evaluations (AU)

Asunto(s)

RESUMEN

OBJECTIVE: To analyze cervical cancer screening performed in Cantabria by evaluating the coverage and costs of screening and by calculating the available direct costs of the disease and the indirect costs of cervical cancer mortality. METHODS: Screening for cervical cancer is performed in women aged between 21 and 65. According to the census for 2011 in Cantabria, there were 189.111 women in this age group. We performed a cross sectional, quantitative and qualitative study of the Pap smears performed and analyzed the direct and indirect costs of cervical cancer. RESULTS: Between 2006 and 2011, 51% of women studied had one Pap smear, and 26% had two. In 2011, 31.554 Pap smears were performed in opportunistic screening in Cantabria, and the direct cost was 2,904.760 €. The annual direct cost of cervical cancer (average 2008-2010) was 567.567 €. The annual indirect costs (average 2001-2008) of cervical cancer was 386.122.02 €, in the reference scenario considered. CONCLUSIONS: Only 26% of women in Cantabria attended screening within the intervals recommended in the current opportunistic protocol. The cost data provided in this study may be useful for future economic evaluations.

Asunto(s)